These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

571 related items for PubMed ID: 23178213

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
    Lakshman JP, Cao Y, Kowalski J, Serajuddin AT.
    Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
    Mitra A, Li L, Marsac P, Marks B, Liu Z, Brown C.
    Int J Pharm; 2016 May 30; 505(1-2):107-14. PubMed ID: 27012984
    [Abstract] [Full Text] [Related]

  • 7. Recent studies on the processes and formulation impacts in the development of solid dispersions by hot-melt extrusion.
    Tran PHL, Lee BJ, Tran TTD.
    Eur J Pharm Biopharm; 2021 Jul 30; 164():13-19. PubMed ID: 33887388
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
    Meng F, Gala U, Chauhan H.
    Drug Dev Ind Pharm; 2015 Jul 30; 41(9):1401-15. PubMed ID: 25853292
    [Abstract] [Full Text] [Related]

  • 12. A combined mathematical model linking the formation of amorphous solid dispersions with hot-melt-extrusion process parameters.
    Schittny A, Ogawa H, Huwyler J, Puchkov M.
    Eur J Pharm Biopharm; 2018 Nov 30; 132():127-145. PubMed ID: 30240820
    [Abstract] [Full Text] [Related]

  • 13. Navigating the Solution to Drug Formulation Problems at Research and Development Stages by Amorphous Solid Dispersion Technology.
    Tripathi D, B H MP, Sahoo J, Kumari J.
    Recent Adv Drug Deliv Formul; 2024 Nov 30; 18(2):79-99. PubMed ID: 38062659
    [Abstract] [Full Text] [Related]

  • 14. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.
    Vo CL, Park C, Lee BJ.
    Eur J Pharm Biopharm; 2013 Nov 30; 85(3 Pt B):799-813. PubMed ID: 24056053
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
    Bikiaris DN.
    Expert Opin Drug Deliv; 2011 Nov 30; 8(11):1501-19. PubMed ID: 21919807
    [Abstract] [Full Text] [Related]

  • 17. Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol®: a Review.
    Ellenberger DJ, Miller DA, Williams RO.
    AAPS PharmSciTech; 2018 Jul 30; 19(5):1933-1956. PubMed ID: 29846889
    [Abstract] [Full Text] [Related]

  • 18. Multiple Linear Regression Modeling To Predict the Stability of Polymer-Drug Solid Dispersions: Comparison of the Effects of Polymers and Manufacturing Methods on Solid Dispersion Stability.
    Fridgeirsdottir GA, Harris RJ, Dryden IL, Fischer PM, Roberts CJ.
    Mol Pharm; 2018 May 07; 15(5):1826-1841. PubMed ID: 29533634
    [Abstract] [Full Text] [Related]

  • 19. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN, Vemavarapu C, Lodaya M.
    Int J Pharm; 2007 Jan 10; 328(2):119-29. PubMed ID: 16968659
    [Abstract] [Full Text] [Related]

  • 20. Building a better particle: Leveraging physicochemical understanding of amorphous solid dispersions and a hierarchical particle approach for improved delivery at high drug loadings.
    Schenck L, Mann AKP, Liu Z, Milewski M, Zhang S, Ren J, Dewitt K, Hermans A, Cote A.
    Int J Pharm; 2019 Mar 25; 559():147-155. PubMed ID: 30654058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.